๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
PK and PD of YG1699 in CKD Patients With Diabetes
NCT06648876Diabetes, Renal Insufficiency, Chronic, Hemodialysis
RenJi Hospital
Phase 1
20
Shanghai
2024-10-31
Recruiting
Efficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus
NCT06691152Systemic Lupus Erythematosus
The Children's Hospital of Zhejiang University School of Medicine
Phase 1
18
Hangzhou
2024-10-30
Recruiting
A Multi-center Open Label Prospective Study on Early Initiation of Targeted-release Formulation of Budesonide in Patients With Primary IgA Nephropathy
NCT06676007IgA Nephropathy (IgAN), Early Initial Therapy
Sichuan Provincial People's Hospital
Observational
200
Chengdu
2024-10-30
Recruiting
A First-in-Human Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of a Novel CRISPR RNA-editing Therapy in Patients with Mecp2 Duplication Syndrome, a Rare Orphan Disease (HERO)
NCT06615206MECP2 Duplication Syndrome
HuidaGene Therapeutics Co., Ltd.
Not applicable
6
Beijing
2024-10-30
Not yet open
Molecular Subtype Combined with Early Minimal Residual Disease to Optimize the Treatment of Newly Diagnosed Acute Myeloid Leukemia
NCT06652685Acute Myeloid Leukemia (AML)
Ruijin Hospital
Phase 2
218
Shanghai
2024-10-30
Active, closed
Zanubrutinib Plus Rituximab as Front-line Treatment for Mucosa-associated Lymphoid Tissue Lymphoma (MALT)
NCT06647732Mucosa-associated Lymphoid Tissue Lymphoma (MALT)
Sun Yat-sen University
Phase 2
42
Guangzhou
2024-10-30
Not yet open
Establishment of a Cohort for Continuous Coronary Artery CTA Scanning and Predictive Analysis of Plaque Progression
NCT06660485CAD - Coronary Artery Disease
West China Hospital
Observational
5,000
Sichuan
2024-10-30
Recruiting
A Study of the ILB-3101 in Patients with Advanced Solid Tumors
NCT06426680Advanced Solid Tumor
Innolake Biopharm
Phase 1
240
Shanghai
2024-10-30
Active, closed
A Study of SKB264 in Combination With Pembrolizumab Versus Chemotherapy in Combination With Pembrolizumab as First-Line Treatment for PD-L1 Negative Patients With Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
NCT06711900Non-Small Cell Lung Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 3
432
Beijing, Changchun, Changcun, Changsha, Chengdu, Chongqing, Dalian, Fuzhou
2024-10-30
Not yet open
A Prospective Cohort of Patients With Cervical/Intracranial Arteries Stenosis in China
NCT06595342Cervical Artery Stenosis, Intracranial Artery Stenosis
The First Hospital of Jilin University
Observational
60,000
Changchun
2024-10-30
Recruiting
Multicenter iTBS Neuromodulation for PTSD Treatment
NCT06434766Posttraumatic Stress Disorder
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
140
Shanghai, Hangzhou, Ningbo
2024-10-30
Recruiting
Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors
NCT06819215Cancer, Neoplasms, Neoplasms, Breast, Tumor
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
Phase 1/2
188
Jinan
2024-10-30
Recruiting
Sentinel Lymph Node Mapping With Different Injection Sites of ICG in Endometrium Cancer
NCT06656949Endometrial Cancer
Qilu Hospital of Shandong University
Not applicable
42
Jinan
2024-10-30
Recruiting
A Study of HS-20124 in Patients with Advanced Solid Tumors
NCT06763159Solid Cancer
Hansoh BioMedical R&D Company
Phase 1
450
Shanghai
2024-10-30
Recruiting
A Prospective Multicenter Clinical Study๏ผš IntracOronary neaR-Infrared Spectroscopy and OptIcal Coherence Tomography for Evaluating Coronary vulNerable Plaque in Patients With diabeTes
NCT06649305Coronary Heart Disease (CHD), Diabetes (DM)
Shanghai Zhongshan Hospital
Observational
1,516
Shanghai
2024-10-30
Recruiting
Spironolactone Improved Children With Gene Mutations Related to NCOR
NCT06678685NCOR Gene Mutations, Spironolactone, ASD
Qilu Hospital of Shandong University
Phase 2/3
2
Jinan
2024-10-30
By invitation
A Multicenter, Randomized, Controlled Trial of Prednisone Combined With Ursodeoxycholic Acid in the Treatment of Primary Biliary Cholangitis With Moderate to Severe Interface Hepatitis Characteristics
NCT06591468Primary Biliary Cholangitis (PBC)
Han Ying
Phase 2/3
244
Guangzhou, Xi'an
2024-10-30
Active, closed
A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations
NCT06644768Non-small Cell Lung Cancer, Lung Cancer
Daiichi Sankyo
Phase 1/2
137
Changchun, Hangzhou, Harbin, Jiamusi, Shanghai, Tiyuan, Zhengzhou
2024-10-30
Not yet open
Current Status of Diagnosis and Treatment of Uroepithelial Carcinoma
NCT06663735Uroepithelial Carcinoma
The First Affiliated Hospital of Xinxiang Medical College
Observational
400
Kaifeng, Luoyang, Nanyang, Puyang, Xinxiang, Zhengzhou
2024-10-30
Recruiting
Evaluation of the Effectiveness and Safety of Laparoscopic Assisted Mastectomy With Preservation of Nipple and Areola, Immediate One-step Breast Reconstruction With Pectoral Muscle Prosthesis and Patch, and Simultaneous Autologous Fat Transplantation
NCT07037537Breast Cancer Patients
Henan Cancer Hospital
Not applicable
26
Zhengzhou
2024-10-30
Recruiting
Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse Prevention
NCT06686108T-cell Acute Lymphoblastic Leukemia, ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Relapse
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2
59
Shanghai
2024-10-30
Not yet open
Anlotinib Plus Benmelstobart and AG in First-line Treatment of Advanced Metastatic Pancreatic Cancer (ALTER-PA-001)
NCT06621095Pancreatic Cancer, First-line, Metastatic Pancreatic Cancer
RenJi Hospital
Phase 2
104
Shanghai
2024-10-30
Not yet open
Safety and Efficacy of Edaravone Dexborneol for Acute Ischemic Stroke
NCT06645522Acute Ischemic Stroke
Yi Yang
Phase 4
1,200
Changchun
2024-10-30
Recruiting
A Study of GNC-077 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors
NCT06609187Breast Cancer, Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
20
Beijing
2024-10-30
Active, closed
NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCC
NCT06762158Esophageal Squamous Cell Carcinoma (ESCC)
RenJi Hospital
Not applicable
50
Shanghai
2024-10-30
Not yet open
Risk Stratification and Early Prevention Strategies for Non-compaction of Ventricular Myocardium (CAPTAIN)
NCT06504056Isolated Noncompaction of the Ventricular Myocardium
First Affiliated Hospital Xi'an Jiaotong University
Observational
2,000
Xi'an
2024-10-30
Recruiting
Evaluation of Safety, Efficacy, and Pharmacokinetics of BT-114143 Injection in Patients With Abnormal Uterine Bleeding
NCT07169214Abnormal Uterine Bleeding
ScinnoHub Pharmaceutical Co., Ltd.
Phase 1
39
Beijing
2024-10-30
Recruiting
A Phase 3 Study of AK112 Plus AK117 Versus Pembrolizumab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
NCT06601335Head and Neck Squamous Cell Carcinoma
Akeso
Phase 3
510
Wuhan, Chengdu
2024-10-30
Active, closed
Phase II Study of Sonrotoclax Combined With Chemotherapy in the Treatment of Newly Diagnosed Acute Myeloid Leukemia
NCT06497062Acute Myeloid Leukemia
Shanghai Jiao Tong University School of Medicine
Phase 2
47
Shanghai
2024-10-30
Not yet open
A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovyยฎ
NCT06633783Obesity
Hangzhou Jiuyuan Gene Engineering Co. Ltd.,
Phase 3
370
Xuancheng, Huizhou, Luoyang, Nanyang, Zhengzhou, Yichang, Huaian, Lianyungang
2024-10-30
Not yet open
A Study of HS-20106 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes
NCT06594965Myelodysplastic Syndromes, Anemia, MDS, Bone Marrow Disease
Hansoh BioMedical R&D Company
Phase 2
176
Tianjin
2024-10-30
Not yet open
The Effectiveness and Safety of Glofitamab in Real-World Clinical Practice Among Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Prospective, Observational, Multicenter Study
NCT06656234Diffuse Large B Cell Lymphoma (DLBCL)
Ruijin Hospital
Observational
200
Shanghai
2024-10-30
Recruiting
A Stuty on the Treatment and Nursing Care of CIPN Patients With Traditional Chinese Medicine Hot Package
NCT06492083Chemotherapy
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Not applicable
90
Yiwu
2024-10-30
Recruiting
Neoadjuvant Radiotherapy for Locally Advanced Unresectable Thymoma
NCT06924619Locally Advanced Thymoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
178
Hangzhou
2024-10-30
By invitation
Adaptive Cognitive Training on Cognitive Function in Elderly Hypertension Patients in the Community
NCT06512922Hypertension, Condition, Aging
Peking University
Not applicable
120
Beijing
2024-10-29
Recruiting
Clinical Application Comparison of Two Femtosecond Laser Systems
NCT06754358Cataract
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1
100
Hangzhou
2024-10-29
Recruiting
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
NCT06663332Crohns Disease, Colitis, Ulcerative, Arthritis, Psoriatic, Arthritis, Juvenile
Janssen Research & Development, LLC
Phase 3
196
Beijing, Changzhou, Hangzhou, Shanghai, Shenyang
2024-10-29
By invitation
Evaluation of [68Ga]DOTA-IR-780-C-4 in PET Imaging Studies for PSMA-Positive Prostate Cancer Patients
NCT07162779PET CT
Affiliated Hospital of Jiangnan University
Not applicable
5
Wuxi
2024-10-29
Recruiting
Effect of Goal-Oriented Albumin Infusion on Postoperative Complication Management in Gastric Cancer Surgery
NCT07119463Postoperative Hypoalbuminemia, Postoperative Complications, Gastric Cancer
The First Hospital of Jilin University
Phase 2
112
Changchun
2024-10-29
Recruiting
Treating Loneliness In The Older Adult With Depression With tDCS
NCT06658795Major Depressive Disorder, Loneliness
Guangzhou Psychiatric Hospital
Not applicable
180
Guangzhou
2024-10-29
Recruiting
An Open-label, Multi-center, Dose-escalation and Cohort Expansion Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Efficacy of ACR246 in Patients With Advanced Solid Tumors
NCT06238401Advanced Solid Tumors
Hangzhou Adcoris Biopharmacy Co., Ltd
Phase 1
77
Beijing, Zhejiang, Shandong, Shanghai
2024-10-29
By invitation
Adaptive Cognitive Training on Cognitive Function in Elderly Diabetes Patients in the Community
NCT06524388Cognition, Diabetes Mellitus, Type 2, Aging
Fanfan Zheng
Not applicable
120
Beijing
2024-10-29
Recruiting
A Clinical Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab or Atezolizumab Combined With Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma
NCT06618664Advanced Hepatocellular Carcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
590
Hefei
2024-10-28
Recruiting
A Study of BGM0504 Injection in Participants with Obesity or Overweight
NCT06704581Overweight or Obesity
BrightGene New Bio-Medical Technology(Wuxi) Co.Ltd.
Phase 3
620
Beijing
2024-10-28
Active, closed
Clinical Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of HSK31858 in Healthy Subjects
NCT07134478Healthy Subjects
Haisco Pharmaceutical Group Co., Ltd.
Phase 1
24
Shanghai
2024-10-28
Active, closed
An Exploratory Study to Evaluate the Tolerability and Safety of MWAV201 in Subjects With Wilson Disease
NCT06663878Wilson Disease
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
9
Shanghai
2024-10-28
Recruiting
Prospective Study of EndoAim: ASUS AI Solution for Colorectal Polyp Diagnosis
NCT06656312Adenoma Colon Polyp
Wen-Hsin Huang
Not applicable
548
2024-10-28
Recruiting
Home- vs Hospital-based Care of Anti-VEGF Treatment for Diabetic Macular Edema: Non-inferiority RCT
NCT06610747Diabetic Macular Edema
Zhongshan Ophthalmic Center, Sun Yat-sen University
Not applicable
308
Dongguan, Foshan, Guangzhou
2024-10-28
Recruiting
Prognostic Biomarkers for Selective Intra-Arterial Cooling Infusion Combined with Endovascular Thrombectomy in Acute Ischemic Stroke Based on Proteomics and Metabolomics.
NCT06665386Stroke, Hypothermia Treatment
Capital Medical University
Observational
258
Dalian
2024-10-27
Active, closed
Neoadjuvant Camrelizumab With Palbociclib for Resectable Esophageal Squamous Cell Carcinomas
NCT06654297Esophageal Squamous Cell Carcinoma
West China Hospital
Phase 1
6
Chengdu
2024-10-27
Not yet open
Vaccine Chatbot for Improving Influenza Vaccination Uptake
NCT06657573Influenza Vaccines
Fudan University
Not applicable
1,200
Hangzhou
2024-10-26
Recruiting
Rapid dFLC Response Predict CHR in AL Amyloidosis
NCT06627309Systemic AL Amyloidosis
Peking University People's Hospital
Observational
50
Beijing, Harbin, Nanjing, Shenyang, Xi'an
2024-10-26
Recruiting
A Real-world Study of Tenecteplase Versus Alteplase for Thrombolysis in Patients Within 4.5 H of Onset of Ischemic Stroke
NCT06621121Stroke Acute, Tenecteplase, Alteplase
Tianjin Huanhu Hospital
Observational
6,000
Tianjin
2024-10-26
Not yet open
Retrospective Analysis of Clinical and CT Features to Predict Spread Through Air Space in Stage IA Lung Adenocarcinoma
NCT06645743Tomography, X-Ray Computed, Spread Through Air Space, Clinical Features, Stage IA Adenocarcinoma of Lung
The Third Affiliated Hospital of Kunming Medical College.
Observational
1,100
Kunming
2024-10-25
Not yet open
Cardiovascular Ultrasound for the Rehabilitation of Patients With Coronary Heart Disease After PCI
NCT06640400Coronary Heart Disease
Qilu Hospital of Shandong University
Not applicable
200
Jinnan
2024-10-25
Recruiting
Effects of Real-time Continuous Glucose Monitoring System on Hospital-to-home Transitional Blood Glucose Control
NCT06591286Diabetes Mellitus, Type 2
Shanghai 6th People's Hospital
Not applicable
150
Shanghai
2024-10-25
Recruiting
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Qifangfeixian Granules in the Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD)
NCT06674148Interstitial Lung Disease, Qifangfeixian Granules
Huilan Zhang
Phase 2/3
124
Wuhan
2024-10-25
Not yet open
Levothyroxine Intervention in Pregnant Women with TSH ๏ผˆ2.5 MIU/L-upper Limit of Reference Range๏ผ‰ and Negative Thyroid Peroxidase Antibody
NCT06653907Thyroid Abnormalities, Pregnant Woman, Pregnancy Outcomes
Yang ZHANG
Phase 4
400
Shijiazhuang
2024-10-25
Recruiting
A Fast, Quiet, Artificial Intelligence-based PET/MR Solution for Paediatric Diseases
NCT06709690Paediatric Patients
Ruijin Hospital
Observational
35
Shanghai
2024-10-25
Recruiting
Clinical Application of FL-091 Radionuclide Imaging in Diagnosis and Staging of Malignant Tumors
NCT06977945Malignant Tumors With Positive NTSR1 Expression
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
100
Wuhan
2024-10-25
Not yet open
Comparing the Safety and Cosmetic Outcomes Between Laparoscopic Versus Traditional Open Breast-conserving Surgery
NCT06671249Breast Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
184
Hangzhou
2024-10-25
By invitation
The Effect of Methylene Blue Infiltrating Injection on Anal Pain After Milligan-Morgan Surgery: A Randomized Controlled Clinical Study
NCT06660680Mixed Hemorrhoids
The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine
Phase 3
60
Hefei
2024-10-25
Recruiting
Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular Carcinoma
NCT06558227Hepatocellular Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 2
90
Chengdu
2024-10-24
Recruiting
Benmelstobart Combined With Radiochemotherapy as Neoadjuvant Treatment Iin ESCC
NCT06637163Esophageal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital
Phase 2
100
Shantou, Shenyang, Shanghai, Tianjin, Hangzhou
2024-10-24
Recruiting
Gemcitabine Hydrochloride, Cisplatin, Nab-Paclitaxel, and Durvalumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer
NCT06591650Gallbladder Cancer Unresectable
Fudan University
Phase 2
33
Shanghai
2024-10-24
Recruiting
Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia
NCT06613880Aplastic Anemia, TPO Receptor Agonists
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
48
Tianjin
2024-10-24
Active, closed
Study on Music Intervention of Non-clinical College Students
NCT06658431Depression Anxiety Disorder
Ye Zhiyin
Not applicable
60
Beijing
2024-10-24
Recruiting
Liposomal Bupivacaine and Bupivacaine for TTMPB in Median Sternotomy
NCT06646172Median Sternotomy
Tongji Hospital
Not applicable
38
Wuhan
2024-10-24
Recruiting
Comparing the Efficacy of Domestic Versus Imported Hearing Aids in ARHL
NCT06882889Age-related Hearing Loss, Hearing Loss, Sensorineural
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
80
Guangzhou
2024-10-24
Not yet open
A Study on the Safety and Efficacy of BST08 in Treating Advanced Non-Small Cell Lung Cancer
NCT06643910Non-small Cell Lung Cancer
BioSyngen Pte Ltd
Not applicable
12
Shenzhen
2024-10-24
Recruiting
Changes in Regional Ventilation-Perfusion Match Following Percutaneous Transluminal Angioplasty for Arteriovenous Graft Thrombosis
NCT07613632Arteriovenous Graft Thrombosis, End Stage Renal Disease on Dialysis
First Affiliated Hospital of Wannan Medical College
Observational
20
Wuhu
2024-10-24
Active, closed
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
NCT06653153Alzheimer's Disease
Eli Lilly and Company
Phase 3
1,400
Beijing, Changchun, Changsha, Chengdu, Guangzhou, Hefei, Jinan, Luoyang
2024-10-24
Recruiting
Phase 1/2 Clinical Study of HY07121 Powder for Solution for Infusion in Patients With Advanced Solid Tumors
NCT06639256Safety, Tolerability, Efficacy
Sichuan Huiyu Pharmaceutical Co., Ltd
Phase 1/2
258
Jinan
2024-10-24
Recruiting
Evaluation of the Safety, Tolerability, and Efficacy of LE051 in Patients With Duchenne Muscular Dystrophy
NCT06900049Duchenne Muscular Dystrophy (DMD)
Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1
12
Shanghai
2024-10-24
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors
NCT06656390Advanced Cancer, Advanced Solid Tumors
Shanghai Allink Biotherapeutics Co., Ltd.
Phase 1/2
202
Hefei, Fuzhou, Xiamen, Guangzhou, Shantou, Nanning, Chengde, Harbin
2024-10-24
Active, closed
Phase I Study of WJ47156 Monotherarpy and in Combination With Other Therapy in Advanced Solid Tumors
NCT06571422Advanced Malignant Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Phase 1
59
Guangzhou
2024-10-23
Recruiting
The Effects of the Control Strategies of Wearable Lower Limb Rehabilitation Robots
NCT07037849Stroke, Gait Training, Gait Disorders
Eighth Affiliated Hospital, Sun Yat-sen University
Not applicable
10
Shenzhen
2024-10-23
Recruiting
A Prospective Study Evaluating the Impact of Conservative Management on Retained Products of Conception and EMV
NCT06862089Retained Products of Conception, Miscarriage, Conservative Management
Fu Xing Hospital, Capital Medical University
Observational
120
Beijing
2024-10-23
Recruiting
A Study of OL-101 Injection in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
NCT06644118Multiple Myeloma
Zhejiang University
Phase 1
58
Beijing, Xiโ€™an, Hangzhou
2024-10-23
Active, closed
A Study of Single Dose of LP-003 in Healthy Adult Subjects
NCT06604949Chronic Spontaneous Urticaria
Longbio Pharma
Phase 1
12
Shanghai
2024-10-23
Recruiting
Sintilimab Plus AVD in Pediatric Low/Moderate Risk Hodgkin Lymphoma: A Phase II Study
NCT06848569Classical Hodgkin Lymphoma
Sun Yat-sen University
Phase 2
73
Guangzhou
2024-10-23
Recruiting
OBINOTUZUMAB Versus Cyclophosphamide + Glucocorticoids in Primary Membranous Nephropathy(Blossom Study)
NCT06781944Primary Membranous Nephropathy
Huashan Hospital
Phase 3
144
Shanghai
2024-10-23
Recruiting
Arsenous Acid for Refractory Triple-Negative Breast Cancer
NCT06678048Breast Cancer
Sun Yat-sen University
Phase 2
12
Guangzhou
2024-10-23
Recruiting
The Effect of Coffee on People with High Intensity Exercise and the Characteristics of Caffeine Metabolism
NCT06712667Healthy
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
Not applicable
24
Shenzhen
2024-10-23
Recruiting
The Effect of Coffee on Energy Expenditure and Caffeine Metabolism
NCT06712511Healthy
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
Not applicable
60
Shenzhen
2024-10-23
Recruiting
Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine
NCT06617715Pneumococcal Infectious Disease
Sinovac Life Sciences Co., Ltd.
Phase 3
3,080
Zhengzhou
2024-10-23
Recruiting
The Modified "Pills-in-the-Pocket" Strategy
NCT06657404Atrial Fibrillation (AF)
Yumei Xue
Not applicable
328
Guangzhou
2024-10-23
Recruiting
Value of Super-resolution Ultrasonography in Differentiating Benign and Malignant Lymph Nodes
NCT07155954Lymphadenopathy, Lymphnode Metastasis, Lymphoma, Lymphatic Tuberculosis
Peking University Third Hospital
Observational
779
Beijing
2024-10-23
Recruiting
A Clinical Study of JMT101 in Combination With Osimertinib Versus Osimertinib Alone as First-Line Treatment for Patients With Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Sensitive Mutations
NCT06735391Locally Advanced or Metastatic Non-squamous NSCLC, Harboring EGFR Sensitive Mutations NSCLC, Previously Untreated Systematically NSCLC
Shanghai JMT-Bio Inc.
Phase 3
516
Guangzhou
2024-10-23
Recruiting
Application of Amide Proton Transfer-Weighted Imaging in Predicting Pathological Complete Response After Neoadjuvant Therapy of Rectal Cancer
NCT06719414Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University
Observational
320
Guangzhou, Maoming
2024-10-22
Recruiting
QL0911 for the Treatment of Cancer Treatment-Induced Thrombocytopenia
NCT06456528Cancer Treatment-Induced Thrombocytopenia
Qilu Pharmaceutical Co., Ltd.
Phase 2/3
235
Harbin, Nanjing
2024-10-22
Active, closed
A Study of JNJ-80948543 in Combination With Other CD3 T-Cell Engagers in Participants With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R B-Cell NHL)
NCT06660563Lymphoma, Non-Hodgkin
Janssen Research & Development, LLC
Phase 1
19
2024-10-22
By invitation
A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Bronchial Asthma
NCT06637254Bronchial Asthma
Haisco Pharmaceutical Group Co., Ltd.
Phase 2
219
Shanghai
2024-10-22
Recruiting
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
NCT06629779Metastatic Castration-Resistant Prostate Cancer
Pfizer
Phase 3
900
Wuhu, Beijing, Fuzhou, Guangzhou, Shantou, Guilin, Xinxiang, Zhengzhou
2024-10-22
Not yet open
Levofloxacin Plus Metronidazole Suppositories Versus Levofloxacin Co-administered with Metronidazole Tablets in Chronic Endometritis
NCT06650540IVF
Peking University Third Hospital
Not applicable
800
Beijing
2024-10-22
Recruiting
Sintilimab With P-GEMOX Versus the P-GEMOX in the Teatment of Advanced-stage Extranodal Natural Killer/T Cell Lymphoma
NCT06583083Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
Sun Yat-sen University
Phase 2
84
Guangzhou
2024-10-22
Recruiting
Effectiveness of Enhanced External Counterpulsation for Post-acute Stroke Patients
NCT06711003Cerebrovascular Accident (CVA)
China Medical University Hospital
Not applicable
110
2024-10-22
Recruiting
A Study in Chinese Patients With Acquired Blepharoptosis
NCT06683651Blepharoptosis
Santen Pharmaceutical Co., Ltd.
Phase 3
180
Hefei, Beijing, Shantou, Guiyang, Zhengzhou, Haโ€™erbin, Wuhan, Xiangyang
2024-10-22
Recruiting
INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use
NCT06314282Systemic Lupus Erythematosus (SLE)
AstraZeneca
Observational
200
Guangzhou, Hong Kong, Shenzhen, Zhongshan, Zhuhai
2024-10-22
Recruiting
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
NCT06623422Carcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC
Phase 3
680
2024-10-21
Rows per page Showing 11001–11100 of 19052
Previous 109 110 111 112 113 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=111

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.